Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.

by Anna Miquel-Cases, Valesca P Retèl, Bianca Lederer, Gunter von Minckwitz, Lotte M G Steuten, Wim H van Harten
Published 2016-01-01

Whole genome sequencing in oncology: using scenario drafting to explore future developments

by Michiel van de Ven, Martijn J. H. G. Simons, Hendrik Koffijberg, Manuela A. Joore, Maarten J. IJzerman, Valesca P. Retèl, Wim H. van Harten
Published 2021-05-01

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

by Valesca P. Retèl, Lotte M. G. Steuten, Marnix H. Geukes Foppen, Janne C. Mewes, Melanie A. Lindenberg, John B. A. G. Haanen, Wim H. van Harten
Published 2018-09-01

GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial

by Neeltje J. van Soolingen, Carolina H. Smorenburg, Marije E. Hamaker, Wim G. Groen, Valesca P. Retèl, Christianne A. R. Lok, Lonneke V. van de Poll-Franse, Johannes W. Trum
Published 2020-02-01

Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?

by Ann-Jean C C Beck, Jacobien M Kieffer, Valesca P Retèl, Lydia F J van Overveld, Robert P Takes, Michiel W M van den Brekel, Wim H van Harten, Martijn M Stuiver
Published 2019-01-01

Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for p...

by Ann-Jean C. C. Beck, Ellen Passchier, Valesca P. Retèl, Martijn M. Stuiver, Lisette van der Molen, Willem M. C. Klop, Arash Navran, Wim H. van Harten, Michiel W. M. van den Brekel
Published 2019-07-01

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based...

by Barbara M. Wollersheim, Kristel M. van Asselt, Henk G. van der Poel, Henk C. P. M. van Weert, Michael Hauptmann, Valesca P. Retèl, Neil K. Aaronson, Lonneke V. van de Poll-Franse, Annelies H. Boekhout
Published 2020-07-01

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists

by Danalyn Byng, Valesca P. Retèl, Ellen G. Engelhardt, Catharina G. M. Groothuis-Oudshoorn, Janine A. van Til, Renée S. J. M. Schmitz, Frederieke van Duijnhoven, Jelle Wesseling, Eveline Bleiker, Wim H. van Harten, on behalf of the Grand Challenge Precision Consortium
Published 2021-08-01

The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized controlled trial

by Jacqueline A. ter Stege, Leonie A. E. Woerdeman, Daniela E. E. Hahn, Martine A. van Huizum, Frederieke H. van Duijnhoven, Jacobien M. Kieffer, Valesca P. Retèl, Kerry A. Sherman, Arjen J. Witkamp, Hester S. A. Oldenburg, Eveline M. A. Bleiker
Published 2019-08-01

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)

by Kris G. Samsom, Linda J. W. Bosch, Luuk J. Schipper, Paul Roepman, Ewart de Bruijn, Louisa R. Hoes, Immy Riethorst, Lieke Schoenmaker, Lizet E. van der Kolk, Valesca P. Retèl, Geert W. J. Frederix, Tineke E. Buffart, Jacobus J. M. van der Hoeven, Emile E. Voest, Edwin Cuppen, Kim Monkhorst, Gerrit A. Meijer
Published 2020-11-01